WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Garrett T. Potter
Associate
Litigation
Seattle
gpotter@wsgr.com

D206-883-2562

Download vCard
Open PDF

Dr. Garrett T. Potter is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent litigation group. His practice focuses on representing clients in Patent Trial and Appeal Board proceedings such as inter partes review and post-grant review. His practice also includes patent prosecution in a wide array of technologies such as chemical, pharmaceutical, mechanical device, and life science industries.

Garrett’s scientific experience involves both industry and academia. He received his Ph.D. in chemistry from The University of Manchester, where he researched medicinal carbohydrate chemistry for the development of an oncological target inhibitor. Before attending graduate school, he worked in the pharmaceutical industry with biopharmaceutical start-ups in San Diego.

Prior to joining the firm, he conducted postdoctoral research at Stanford University and The University of Manchester, focusing on medicinal and carbohydrate chemistries.

Experience

Dr. Garrett T. Potter is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent litigation group. His practice focuses on representing clients in Patent Trial and Appeal Board proceedings such as inter partes review and post-grant review. His practice also includes patent prosecution in a wide array of technologies such as chemical, pharmaceutical, mechanical device, and life science industries.

Garrett’s scientific experience involves both industry and academia. He received his Ph.D. in chemistry from The University of Manchester, where he researched medicinal carbohydrate chemistry for the development of an oncological target inhibitor. Before attending graduate school, he worked in the pharmaceutical industry with biopharmaceutical start-ups in San Diego.

Prior to joining the firm, he conducted postdoctoral research at Stanford University and The University of Manchester, focusing on medicinal and carbohydrate chemistries.

Education
  • J.D., University of Notre Dame Law School

    Magna cum laude; Award for Outstanding Achievement in the Program of Study in Intellectual Property and Technology Law; Faculty Awards for Excellence: Patent Law, Remedies, Legal Writing I; Dean’s Circle Fellow

  • Ph.D., Chemistry, The University of Manchester, United Kingdom
  • B.S., Biochemistry/Chemistry, University of California, San Diego
Associations and Memberships
  • Member, American Chemical Society
Admissions
  • State Bar of Washington
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of Notre Dame Law School

    Magna cum laude; Award for Outstanding Achievement in the Program of Study in Intellectual Property and Technology Law; Faculty Awards for Excellence: Patent Law, Remedies, Legal Writing I; Dean’s Circle Fellow

  • Ph.D., Chemistry, The University of Manchester, United Kingdom
  • B.S., Biochemistry/Chemistry, University of California, San Diego
Associations and Memberships
  • Member, American Chemical Society
Admissions
  • State Bar of Washington
  • U.S. Patent and Trademark Office

Select Publications

  • “Federal Circuit Versus Administrative Agencies: Patent Expert Witnesses After Kyocera,” 2023(2) J.L. Tech. & Pol’y 223, 2023

  • “Beefing Up Skinny Labels: Induced Infringement as a Question of Law,” 97 Notre Dame L. Rev. 1707, 2022

  • Co-author with G. Jayson, G. Miller, and J. Gardiner, "An Updated Synthesis of the Diazo-Transfer Reagent Imidazole-1-sulfonyl Azide Hydrogen Sulfate," 81(8) The Journal of Organic Chemistry 3443-6, 2016
  • Co-author with A. Ni Cheallaigh, J. Gardiner, and G. Miller, "Preparation of Methyl 1,2,3,4-tetra-O-acetyl-β-D-glucopyranuronate," 93 Organic Synthesis 200-9, 2016
  • Co-author with G. Jayson, G. Miller, and J. Gardiner, "Amyl nitrite-mediated conversion of aromatic and heteraromatic primary amides to carboxylic acids," 56(37) Tetrahedron Letters 5153-6, 2015
Insights

Select Publications

  • “Federal Circuit Versus Administrative Agencies: Patent Expert Witnesses After Kyocera,” 2023(2) J.L. Tech. & Pol’y 223, 2023

  • “Beefing Up Skinny Labels: Induced Infringement as a Question of Law,” 97 Notre Dame L. Rev. 1707, 2022

  • Co-author with G. Jayson, G. Miller, and J. Gardiner, "An Updated Synthesis of the Diazo-Transfer Reagent Imidazole-1-sulfonyl Azide Hydrogen Sulfate," 81(8) The Journal of Organic Chemistry 3443-6, 2016
  • Co-author with A. Ni Cheallaigh, J. Gardiner, and G. Miller, "Preparation of Methyl 1,2,3,4-tetra-O-acetyl-β-D-glucopyranuronate," 93 Organic Synthesis 200-9, 2016
  • Co-author with G. Jayson, G. Miller, and J. Gardiner, "Amyl nitrite-mediated conversion of aromatic and heteraromatic primary amides to carboxylic acids," 56(37) Tetrahedron Letters 5153-6, 2015
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Litigation
  • Patent Litigation
  • Patents and Innovations
  • Post-Grant Review
Recent Insights
News Articles
WIPR Recognizes Wilson Sonsini in USA Patent Rankings 2025
World Intellectual Property Review (WIPR) recognized Wilson Sonsini’s patents practice in the 2025 edition of “WIPR USA Patents,” a comprehensive analysis of the leading law firms and attorneys in the U.S. Wilson Sonsini is ranked as a “Recommended Firm” and is noted for its patent work and for its bench of deeply knowledgeable practitioners. The firm is also recognized for its work in cutting-edge technology sectors, including artificial intelligence and machine learning.
Learn More
Client Highlights
Wilson Sonsini Secures PTAB Institution in Five IPRs Filed for Azurity Pharmaceuticals
On November 19, 2025, Wilson Sonsini obtained a significant milestone for Azurity Pharmaceuticals, with the Patent Trial and Appeal Board (PTAB) instituting inter partes review in all five petitions the firm filed on Azurity’s behalf. The petitions challenge methods and compositions for treating chemotherapy-induced nausea and vomiting. The Board’s institution decisions found a reasonable likelihood that Azurity will prevail on at least one challenged claim in each proceeding and authorized full trials on the grounds raised. The Board’s decisions are a notable milestone in the current PTAB environment, where institution rates have tightened significantly. Three Administrative Patent Judges independently concluded the challenges were reasonably likely to succeed, and the cases will now proceed to the yearlong trial phase. 
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.